NPCE
NeuroPace, Inc. NASDAQ Listed Apr 22, 2021$19.29
Mkt Cap $654.9M
52w Low $7.56
98.7% of range
52w High $19.44
50d MA $14.90
200d MA $13.18
P/E (TTM)
-25.9x
EV/EBITDA
-38.5x
P/B
29.4x
Debt/Equity
3.7x
ROE
-112.8%
P/FCF
-44.6x
RSI (14)
—
ATR (14)
—
Beta
1.88
50d MA
$14.90
200d MA
$13.18
Avg Volume
194.6K
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
CIK (SEC)
Phone
650 237 2700
455 North Bernardo Avenue · Mountain View, CA 94043 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | AMC | -0.14 | -0.08 | +42.9% | 13.83 | +12.7% | +0.9% | -1.7% | +1.4% | +1.6% | +2.8% | — |
| Nov 4, 2025 | AMC | -0.20 | -0.11 | +45.0% | 9.40 | +23.7% | +38.1% | +36.0% | +39.6% | +43.1% | +43.5% | — |
| Aug 12, 2025 | AMC | -0.24 | -0.26 | -8.3% | 9.13 | -2.0% | +2.1% | -1.1% | -6.2% | -7.8% | -9.6% | — |
| May 13, 2025 | AMC | -0.26 | -0.21 | +19.2% | 12.95 | +10.4% | +20.5% | +31.9% | +35.1% | +31.3% | +38.9% | — |
| Mar 4, 2025 | AMC | -0.25 | -0.18 | +28.0% | 11.92 | +6.1% | -2.4% | -6.2% | -7.7% | -15.8% | -13.1% | — |
| Nov 12, 2024 | AMC | -0.26 | -0.19 | +26.9% | 7.14 | +8.1% | +28.2% | +35.6% | +25.8% | +25.4% | +28.6% | — |
| Aug 13, 2024 | AMC | -0.29 | -0.26 | +10.3% | 7.28 | +0.3% | -7.0% | -2.5% | -5.6% | -2.5% | -0.5% | — |
| May 8, 2024 | AMC | -0.32 | -0.32 | +0.0% | 12.60 | -1.4% | -36.7% | -32.5% | -32.4% | -32.5% | -28.3% | — |
| Mar 5, 2024 | AMC | -0.33 | -0.23 | +30.3% | 14.20 | +0.7% | -1.5% | -0.5% | +0.1% | -4.2% | -3.7% | — |
| Nov 6, 2023 | AMC | -0.39 | -0.28 | +28.2% | 7.20 | -3.1% | -1.8% | +0.7% | +7.5% | +9.0% | +17.9% | — |
| Aug 8, 2023 | AMC | -0.47 | -0.36 | +23.4% | 4.10 | +6.1% | +9.8% | +9.8% | +9.8% | +9.0% | +9.8% | — |
| May 4, 2023 | AMC | -0.46 | -0.41 | +10.9% | 4.99 | +2.6% | -0.8% | +2.7% | -6.0% | -3.8% | -10.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.23 | $16.21 | -0.1% | -1.7% | -3.8% | -5.6% | -6.8% | -2.0% |
| Dec 16 | UBS | Maintains | Buy → Buy | — | $15.92 | $16.00 | +0.5% | -0.3% | -1.9% | -1.1% | +4.2% | +4.0% |
| Dec 10 | JP Morgan | Maintains | Overweight → Overweight | — | $16.27 | $16.74 | +2.9% | +3.1% | +1.3% | -0.5% | -2.2% | -2.4% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.40 | $11.63 | +23.7% | +38.1% | +36.0% | +39.6% | +43.1% | +43.5% |
| Nov 5 | JP Morgan | Maintains | Overweight → Overweight | — | $9.40 | $11.63 | +23.7% | +38.1% | +36.0% | +39.6% | +43.1% | +43.5% |
| Aug 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.13 | $8.95 | -2.0% | +2.1% | -1.1% | -6.2% | -7.8% | -9.6% |
| May 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.95 | $14.30 | +10.4% | +20.5% | +31.9% | +35.1% | +31.3% | +38.9% |
| May 14 | JP Morgan | Maintains | Overweight → Overweight | — | $12.95 | $14.30 | +10.4% | +20.5% | +31.9% | +35.1% | +31.3% | +38.9% |
| Apr 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $10.42 | $10.74 | +3.1% | +2.4% | -0.8% | +0.1% | +3.6% | +1.2% |
| Mar 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $11.92 | $12.65 | +6.1% | -2.4% | -6.2% | -7.7% | -15.8% | -13.1% |
| Jan 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.69 | $14.99 | +2.0% | -3.4% | -6.3% | -7.4% | -5.4% | -2.7% |
| Dec 17 | JP Morgan | Maintains | Overweight → Overweight | — | $11.47 | $11.59 | +1.0% | +0.4% | -7.2% | -2.9% | +0.5% | -0.3% |
| Nov 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.14 | $7.72 | +8.1% | +28.2% | +35.6% | +25.8% | +25.4% | +28.6% |
| Aug 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.28 | $7.30 | +0.3% | -7.0% | -2.5% | -5.6% | -2.5% | -0.5% |
| Aug 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.28 | $7.30 | +0.3% | -7.0% | -2.5% | -5.6% | -2.5% | -0.5% |
| Jul 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.44 | $7.42 | -0.3% | +3.5% | +7.8% | +0.9% | -1.9% | +7.0% |
| May 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.60 | $12.42 | -1.4% | -36.7% | -32.5% | -32.4% | -32.5% | -28.3% |
| Mar 14 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $13.38 | $14.36 | +7.3% | +1.9% | -1.5% | -4.0% | +0.5% | +1.9% |
| Mar 12 | JP Morgan | Maintains | Overweight → Overweight | — | $13.60 | $13.92 | +2.4% | +0.5% | -1.6% | +0.2% | -3.1% | -5.6% |
| Mar 6 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $14.20 | $14.30 | +0.7% | -1.5% | -0.5% | +0.1% | -4.2% | -3.7% |
| Mar 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $14.20 | $14.30 | +0.7% | -1.5% | -0.5% | +0.1% | -4.2% | -3.7% |
| Feb 22 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $15.61 | $15.64 | +0.2% | -1.9% | +9.0% | +8.6% | +9.6% | +7.2% |
| Dec 27 | Lake Street | Maintains | Buy → Buy | — | $9.90 | $10.08 | +1.8% | +1.6% | +1.0% | +4.1% | -1.2% | +1.5% |
| Dec 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.90 | $8.85 | -0.6% | -8.7% | -6.6% | -7.6% | -4.6% | -5.6% |
| Nov 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.49 | $8.78 | +3.4% | -1.1% | +2.5% | +3.1% | +1.9% | +2.5% |
| Nov 7 | JP Morgan | Maintains | Overweight → Overweight | — | $7.20 | $6.98 | -3.1% | -1.8% | +0.7% | +7.5% | +9.0% | +17.9% |
| Oct 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $8.41 | $8.21 | -2.4% | -6.7% | -6.5% | -0.7% | -16.6% | -9.6% |
| Aug 24 | Morgan Stanley | Upgrade | Underweight → Equal Weight | — | $4.78 | $4.79 | +0.2% | +7.9% | +25.5% | +45.8% | +86.4% | +80.1% |
| May 5 | Morgan Stanley | Maintains | Underweight → Underweight | — | $4.99 | $5.12 | +2.6% | -0.8% | +2.7% | -6.0% | -3.8% | -10.8% |
| Mar 3 | Morgan Stanley | Maintains | Underweight → Underweight | — | $4.20 | $4.36 | +3.8% | -2.4% | +9.5% | +3.8% | -0.5% | +1.9% |
| Feb 22 | Lake Street | Maintains | Buy → Buy | — | $5.34 | $5.48 | +2.6% | -11.0% | -7.1% | -6.9% | -6.4% | -3.9% |
| Jan 6 | Morgan Stanley | Maintains | Underweight → Underweight | — | $1.53 | $1.62 | +5.5% | +2.9% | +6.2% | +44.0% | +53.1% | +72.6% |
| Oct 11 | Morgan Stanley | Maintains | Underweight → Underweight | — | $3.09 | $3.05 | -1.3% | +2.6% | +1.9% | +1.9% | +1.9% | +5.2% |
| Jul 15 | Morgan Stanley | Maintains | Underweight → Underweight | — | $5.73 | $5.81 | +1.4% | +0.2% | +0.9% | -1.0% | +1.0% | +1.2% |
| May 13 | Morgan Stanley | Maintains | Underweight → Underweight | — | $6.26 | $6.34 | +1.3% | -1.8% | -18.5% | -6.4% | -7.3% | -4.2% |
| May 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $6.26 | $6.34 | +1.3% | -1.8% | -18.5% | -6.4% | -7.3% | -4.2% |
| Apr 6 | Wolfe Research | Maintains | Outperform → Outperform | — | $8.44 | $9.00 | +6.6% | -0.8% | -1.1% | -4.6% | -6.5% | -1.1% |
| Mar 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $7.61 | $7.32 | -3.8% | +6.2% | +9.6% | -1.2% | +5.1% | +9.7% |
| Mar 11 | SVB Leerink | Maintains | Outperform → Outperform | — | $7.61 | $7.32 | -3.8% | +6.2% | +9.6% | -1.2% | +5.1% | +9.7% |
| Jan 19 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $10.04 | $9.20 | -8.4% | -3.0% | -6.3% | -7.8% | -7.5% | -7.7% |
| Jan 7 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $11.57 | $10.41 | -10.0% | -13.2% | -13.2% | -7.4% | -0.8% | -6.7% |
| Aug 18 | Baird | Maintains | Outperform → Outperform | — | $19.85 | $19.81 | -0.2% | -3.1% | -1.8% | -1.7% | +2.6% | +3.1% |
| Jun 3 | SVB Leerink | Maintains | Outperform → Outperform | — | $22.49 | $22.76 | +1.2% | -3.6% | +0.8% | +4.8% | +8.7% | +10.1% |
| May 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +20.1% | +12.7% | +8.7% | +8.4% |
| May 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +20.1% | +12.7% | +8.7% | +8.4% |
| May 17 | JP Morgan | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +20.1% | +12.7% | +8.7% | +8.4% |
| May 17 | SVB Leerink | Maintains | Outperform → Outperform | — | $20.91 | $20.85 | -0.3% | +3.9% | +20.1% | +12.7% | +8.7% | +8.4% |
No insider trades available.
Data updated apr 26, 2026 3:37pm
· Source: massive.com